Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Topical Gel 1% in Acute Ankle Sprain
NCT01255423Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Ankle sprain comparing Diclofenac sodium topical gel 1% with Placebo (2 arms). Primary endpoint: Pain on Movement at 72 hours. Started Nov 2010; status: completed.
02
Drugs
diclofenac sodium
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on NCT01255423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01255423.